What's Next in Precision Medicine: Moving New Discoveries into Daily Clinical Care - Insights
Experts in individualized medicine—the concept of shaping health care based on lifestyle, environment, and genetic code—will be in Rochester September 12–13 to present how the newest discoveries can be applied to personalized health care.
Mayo Clinic released a new DNA product with Helix, a personal genomics company, called "Mayo Clinic GeneGuide." The DNA-powered product provides healthy individuals with genetic testing and insights with a focus on education.
Week in Review: October 4 - Insights
Top highlights include: Flu vaccine information, possible effects that red meat has on the human body, and what vaping does to the lungs.
Week in Review: October 11 - Insights
Top highlights include: Discussions around flu season, teen vaping, spotting signs of cognitive impairment, and DNA tests.
Mayo Clinic Laboratory and Pathology Research Roundup: Nov. 13 - Insights
This week’s Research Roundup highlights how the DnaJ heat shock protein family B member 9 is a novel biomarker for fibrillary GN.
The National Kidney Foundation, the American Society for Clinical Pathology, and the nation’s leading laboratories and clinical laboratory societies have announced a new collaboration to remove barriers to testing for chronic kidney...
Mayo Clinic Laboratory and Pathology Research Roundup: Dec. 10 - Insights
This week’s Research Roundup highlights the evaluation of monoclonal gammopathy of renal significance: A consensus report of the International Kidney and Monoclonal Gammopathy Research Group.
Mayo Clinic Research Advances Diagnostics to Lead COVID-19 Pandemic Response - Insights
When COVID-19 spread across the U.S. in early March, Mayo Clinic’s Advanced Diagnostic Laboratory urgently responded.
Serologic testing for celiac disease in patients with IgA deficiency - Insights
In this month’s “Hot Topic,” Julia Lehman, M.D., discusses serologic testing for Celiac Disease in patients with IgA deficiency.
Mayo Clinic Researchers Find New Way to Improve Newborn Screening of Pompe Disease - Insights
Researchers at Mayo Clinic have discovered a second-tier test for Pompe disease that has been shown to improve the specificity of newborn screening for the disorder, which would lower the rate of false-positive results.